These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22835210)

  • 1. Recent advances in polymeric microspheres for parenteral drug delivery--part 1.
    Mao S; Guo C; Shi Y; Li LC
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1161-76. PubMed ID: 22835210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in polymeric microspheres for parenteral drug delivery--part 2.
    Mao S; Guo C; Shi Y; Li LC
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1209-23. PubMed ID: 22924745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current knowledge on biodegradable microspheres in drug delivery.
    Prajapati VD; Jani GK; Kapadia JR
    Expert Opin Drug Deliv; 2015 Aug; 12(8):1283-99. PubMed ID: 25687105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancement in microsphere preparation using natural polymers and recent patents.
    Farooq U; Malviya R; Sharma PK
    Recent Pat Drug Deliv Formul; 2014; 8(2):111-25. PubMed ID: 24597612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress and challenges for polymeric microsphere compared to nanosphere drug release systems: Is there a real difference?
    Alavi M; Webster TJ
    Bioorg Med Chem; 2021 Mar; 33():116028. PubMed ID: 33508639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGFβ-receptor in the fibrotic kidney.
    Teekamp N; Van Dijk F; Broesder A; Evers M; Zuidema J; Steendam R; Post E; Hillebrands JL; Frijlink HW; Poelstra K; Beljaars L; Olinga P; Hinrichs WLJ
    Int J Pharm; 2017 Dec; 534(1-2):229-236. PubMed ID: 29038068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable polymers for targeted delivery of anti-cancer drugs.
    Doppalapudi S; Jain A; Domb AJ; Khan W
    Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of degradable-polar-hydrophobic-ionic co-polymeric microspheres by membrane emulsion photopolymerization: In vitro and in vivo studies.
    Tawagi E; Ganesh T; Cheng HM; Santerre JP
    Acta Biomater; 2019 Apr; 89():279-288. PubMed ID: 30853610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting injectable microsphere formulation for the parenteral administration of levonorgestrel.
    Beck LR; Pope VZ; Tice TR; Gilley RM
    Adv Contracept; 1985 Jun; 1(2):119-29. PubMed ID: 3939509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
    Hernán Pérez de la Ossa D; Gil-Alegre ME; Ligresti A; Aberturas Mdel R; Molpeceres J; Torres AI; Di Marzo V
    J Drug Target; 2013 Sep; 21(8):710-8. PubMed ID: 23773072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM).
    Feng SS; Ruan G; Li QT
    Biomaterials; 2004 Sep; 25(21):5181-9. PubMed ID: 15109842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.
    Davis SS
    Vaccine; 2006 Apr; 24 Suppl 2():S2-7-10. PubMed ID: 16823907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
    Eniola AO; Hammer DA
    Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].
    Płaczek M; Jacyna J; Sznitowska M
    Pol Merkur Lekarski; 2014 Jan; 36(211):54-8. PubMed ID: 24645581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biodegradable polymers for local growth factor delivery.
    Amsden B
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):318-28. PubMed ID: 26614555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable Polymeric Microsphere-Based Drug Delivery for Inductive Browning of Fat.
    Jiang C; Kuang L; Merkel MP; Yue F; Cano-Vega MA; Narayanan N; Kuang S; Deng M
    Front Endocrinol (Lausanne); 2015; 6():169. PubMed ID: 26617571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.